MedPath

Excelife NerviWell Tablet

Registration Number: MAL23056080NC

Approved
Approval ID

1bdff6b55e8880b3

Registration Number

MAL23056080NC

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types5 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (5)

10 TabletsAvailable
Package Size: 10 Tablets
Status: NPRA Approved
30 TabletsAvailable
Package Size: 30 Tablets
Status: NPRA Approved
60 TabletsAvailable
Package Size: 60 Tablets
Status: NPRA Approved
90 TabletsAvailable
Package Size: 90 Tablets
Status: NPRA Approved
120 TabletsAvailable
Package Size: 120 Tablets
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (6)

PYRIDOXINE HYDROCHLORIDEActive
Monograph: 维生素B6
THIAMINE HYDROCHLORIDEActive
Monograph: 硝酸硫胺
VITAMIN K2Active
Monograph: Menaquinone 6
ALPHA LIPOIC ACIDActive
Monograph: 硫辛酸
METHYLCOBALAMINActive
Monograph: 甲钴胺
GINKGO BILOBA LEAF EXTRACTActive
Monograph: ginkgo biloba leaf extract

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Excelife NerviWell Tablet - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform